Preprint Article Version 1 This version is not peer-reviewed

The Importance of Preoperative NLR, PLR, and MPV Values in Predicting the Risk of Complications in Colorectal Peritoneal Carcinomatosis

Version 1 : Received: 12 July 2024 / Approved: 12 July 2024 / Online: 14 July 2024 (03:11:44 CEST)

How to cite: Özcan, P.; Düzgün, Ö. The Importance of Preoperative NLR, PLR, and MPV Values in Predicting the Risk of Complications in Colorectal Peritoneal Carcinomatosis. Preprints 2024, 2024071091. https://doi.org/10.20944/preprints202407.1091.v1 Özcan, P.; Düzgün, Ö. The Importance of Preoperative NLR, PLR, and MPV Values in Predicting the Risk of Complications in Colorectal Peritoneal Carcinomatosis. Preprints 2024, 2024071091. https://doi.org/10.20944/preprints202407.1091.v1

Abstract

The Importance of Preoperative NLR, PLR, and MPV Values in Predicting the Risk of Complications in Colorectal Peritoneal Carcinomatosis Background Neutrophil-to-lymphocyte ratio (NLR), platelet-to-lymphocyte ratio (PLR), and mean platelet volume (MPV) measurements can be easily assessed in most hospital laboratories. Our aim is to emphasize the importance of preoperative inflammatory parameters such as NLR, PLR, and MPV in predicting postoperative complications in patients undergoing surgery for colorectal peritoneal carcinomatosis (CRC PC). Methods Patients operated for CRC PC were evaluated. Demographic data, NLR, PLR, and MPV values were calculated using the following formulas: NLR = (absolute neutrophil count)/(total lymphocyte count), PLR = (total lymphocyte count)/(total platelet count) × 100, MPV = mean platelet volume calculated by dividing platelet crit (PCT) by total platelet count. Results A total of 196 patients with CRC PC were included in the study. A statistically significant relationship was observed between NLR, PLR, MPV, and OS. Patients with an NLR value of 3.77 had a median OS of 22.1 months, whereas those with an NLR value below 3.77 had a median OS of 58.3 months (HR 2.7, 95% CI 1.1–5.3, p

Keywords

NLR; PLR; MPV; colorectal; peritoneal carcinomatosis

Subject

Medicine and Pharmacology, Surgery

Comments (0)

We encourage comments and feedback from a broad range of readers. See criteria for comments and our Diversity statement.

Leave a public comment
Send a private comment to the author(s)
* All users must log in before leaving a comment
Views 0
Downloads 0
Comments 0
Metrics 0


×
Alerts
Notify me about updates to this article or when a peer-reviewed version is published.
We use cookies on our website to ensure you get the best experience.
Read more about our cookies here.